10 Moderna regulatory affairs leaders
Head, New Product Development Strategy, Global Regulatory Science, Executive Director, Global Regulatory Strategy, Seasonal Vaccines and Director, Global Regulatory Science CMC are among the current titles held by these Moderna regulatory affairs leaders. A reader can learn how regulatory affairs leaders work at Moderna from people who have held the role.
Professionals to explore
Anitia K. Murthy
LinkedInExperience: Senior Director, Global Regulatory Strategy, Oncology · Moderna
Anitia K. Murthy has been Senior Director, Global Regulatory Strategy, Oncology at Moderna since September 2023. Anitia K. Murthy was Senior Director, Global Regulatory Lead, Oncology at Bayer from 2019 to 2023, Deputy Director at Bayer from 2014 to 2019 and Associate Director, New & Emerging Markets, Global Regulatory Affairs at Eisai US from 2012 to 2014.
Antonella Lozito-Heerschap, Pharm.D.
LinkedInExperience: Head, New Product Development Strategy, Global Regulatory Science · Moderna
Antonella Lozito-Heerschap has been Head, New Product Development Strategy, Global Regulatory Science at Moderna since November 2024 and was Executive Director, Regulatory Affairs, Infectious Disease there from 2022 to 2024, based in Denville, New Jersey. Antonella Lozito-Heerschap was Head, Global Regulatory Strategy, Innovative Portfolio at LEO Pharma from 2020 to 2022.
Kelly Hoffner
LinkedInExperience: Executive Director, Global Regulatory Strategy, Seasonal Vaccines · Moderna
Kelly Hoffner has been Executive Director, Global Regulatory Strategy, Seasonal Vaccines at Moderna since November 2024 and was Sr Director, Global Regulatory Strategy, Infectious Diseases there from 2023 to 2024, based in the Washington DC-Baltimore Area. Kelly Hoffner was Senior Global Regulatory Leader for Influenza at GSK from 2016 to 2023 and Director, Regulatory Affairs Influenza Franchise at Sanofi from 2015 to 2016.
Laila El Asmar
LinkedInExperience: Executive Director, Regulatory Strategy, Resilience (UK Australia Canada) Markets · Moderna
Laila El Asmar has been Executive Director, Regulatory Strategy, Resilience (UK Australia Canada) Markets at Moderna since September 2025, based in the Greater Tampa Bay Area. Laila El Asmar was Regulatory Affairs Lead - Neurology Americas at UCB from 2016 to 2020 and Associate Director, Global Regulatory Affairs at UCB from 2013 to 2016, and the listing shows other director-level regulatory roles at Moderna from 2020.
Michelle Olsen
LinkedInExperience: Director - Global Regulatory Strategy - Infectious Diseases - Global Regulatory Sciences · Moderna
Michelle Olsen has been Director - Global Regulatory Strategy - Infectious Diseases - Global Regulatory Sciences at Moderna since November 2023, based in Cambridge, Massachusetts. At Moderna, Michelle Olsen was Associate Director - Regulatory Strategy - Infectious Dieases - Global Regulatory Sciences from 2021 to 2023, and was Manager of Regulatory Affairs at Ora from 2019 to 2020.
Sai Prathyusha Bhamidipati
LinkedInExperience: Director, Reg CMC · Moderna
Sai Prathyusha Bhamidipati has been Director, Reg CMC at Moderna since May 2024, based in Cambridge, Massachusetts. Sai Prathyusha Bhamidipati was Associate Director, Reg CMC (VCGT) at Vertex Pharmaceuticals from 2021 to 2024, Associate Director, Reg CMC at Sage Therapeutics from 2020 to 2021 and Regulatory Affairs Manager,Site CMC at Amgen from 2015 to 2018.
Satya Punyamurthula
LinkedInExperience: Director, Global Regulatory Science CMC · Moderna
Satya Punyamurthula has been Director, Global Regulatory Science CMC at Moderna since November 2024, based in the New York City Metropolitan Area. Satya Punyamurthula was Associate Director, Regulatory Affairs CMC at Pfizer from 2023 to 2024, Associate Director, Regulatory CMC at Seagen in 2023 and Manager, Global Regulatory Strategy - CMC at Takeda from 2020 to 2021.
Thomas Chambers
LinkedInExperience: Senior Director - Regulatory Strategy; Infectious Disease Vaccines · Moderna
Thomas Chambers has been Senior Director - Regulatory Strategy; Infectious Disease Vaccines at Moderna, Inc. since August 2020, based in North Wales, Pennsylvania. Thomas Chambers was Senior Regulatory Director at Merck from 2019 to 2020 and Director Global Regulatory Affairs at Merck and Co., Inc. from 2004 to 2019, and was Associate Professor at SSM Health Saint Louis University Hospital from 1993 to 2004.
Urimara Argotti
LinkedInExperience: Director, Regulatory Science - Latin America · Moderna
Urimara Argotti has been Director, Regulatory Science - Latin America at Moderna since July 2025 and was Associate Director, Regulatory Science, Latin America there from 2024 to 2025, based in Cambridge, Massachusetts. Urimara Argotti was Regional Regulatory Policy LATAM Head at Roche from 2020 to 2023 and Regulatory Affairs Head at Bayer from 2014 to 2015.
Choose the right perspective
Match the scope in a person's title, such as global regulatory strategy for a therapeutic area, regional regulatory science or regulatory CMC, to the question you need answered. Weigh how recently each person held the role and whether a director-level or executive-level view fits your question better.
Questions to take into the conversation
- 01What did you focus on first when you took on your regulatory affairs role at Moderna?
- 02What has changed in how you approach regulatory work since you took on your current role?
- 03What has your own work at Moderna taught you about building a regulatory affairs team?
Reaching Moderna regulatory affairs leaders
How can I contact one of these Moderna regulatory affairs leaders?
Pick one of the 10 people on this page and choose "Book a paid call", or describe your project to find others. You offer a fee for a 15-minute call or a written answer, Instant Expert finds the person's work email and sends the invitation, and they decide whether to accept. The list covers 1 company: Moderna, based on profile data retrieved on October 24, 2026. Being listed here doesn't mean someone has agreed to take calls.
How much does it cost to reach Moderna regulatory affairs leaders?
You choose the offer, starting at $5 per person. The offer is what the person receives, and Instant Expert's fee is added on top, so a $100 offer costs you $125. The fee is 20% of what you pay. You're charged only when the person books the call or sends the answer.
What if they don't reply?
You pay nothing. Instant Expert sends follow-up reminders, and if the person hasn't booked or answered within 7 days, the request expires and any hold on your card is released. You can invite several of the 10 people on this list at once and cap your total spend, so you pay only for the ones who accept.
Can an AI agent ask one of these Moderna regulatory affairs leaders a question?
Yes. An agent with a USDC wallet on Base can ask one question without an Instant Expert account. It names the person, for example by the LinkedIn URL on this page, and pays per ask over x402 (HTTP 402). The person answers in writing or by voice note, and if nobody answers within 7 days, the payment goes back to the wallet automatically. Claude and ChatGPT can do the same through the Instant Expert connector: setup is at /docs/mcp for Claude and /docs/chatgpt for ChatGPT. x402 docs
About this directory
This is a professional research starting point based on business profile data retrieved on . Titles and companies reflect that source snapshot; roles marked former had ended by then. Check the linked profiles for current details. Inclusion does not imply Instant Expert membership or availability.
Request a correction or removal